ACP-2127

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameACP-2127
Drug Alias NameACP-2127
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitorsCyclin-dependent kinase inhibitors
TargetsSerine/threonine-protein kinase mTORCyclin-dependent kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuest Pharmatech Inc
China Registration ClassN/A

Develop Information

Active CompaniesQuest Pharmatech Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A